Debrisoquin sulfate
Code | Size | Price |
---|
TAR-T31272-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T31272-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Debrisoquine is an antihypertensive drug similar to guanethidine.
CAS:
581-88-4
Formula:
C20H28N6O4S
Molecular Weight:
448.54
Purity:
0.98
SMILES:
OS(O)(=O)=O.NC(=N)N1CCc2ccccc2C1.NC(=N)N1CCc2ccccc2C1
References
1. Laine K, Tybring G, H?rtter S, Andersson K, Svensson JO, Wid?n J, Bertilsson L. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Clin Pharmacol Ther. 2001 Oct;70(4):327-35. PubMed PMID: 11673748.
2. Hamelin BA, Turgeon J, Vall?e F, B?langer PM, Paquet F, LeBel M. The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin. Clin Pharmacol Ther. 1996 Nov;60(5):512-21. PubMed PMID: 8941024.
3. Lautenschlager MT, Viktor S, M?ller UA, Hoffmann A. [Comparison of serum concentrations of caffeine, 4-methylaminoantipyrine, sulfamethazine and debrisoquin following oral administration of these substances as a cocktail in type II diabetics before and after insulin therapy]. Pharmazie. 1996 Oct;51(10):750-3. German. PubMed PMID: 8999440.
4. Marandi T, Dahl ML, Kiivet RA, R?go L, Sj?qvist F. Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population. Pharmacol Toxicol. 1996 May;78(5):303-7. PubMed PMID: 8737964.